This study aimed to evaluate sex differences in pulmonary and systemic vascular hemodynamics assessed by RHC at rest and during exercise in otherwise healthy individuals. In the pulmonary circuit, we observed significantly greater TPulmR as well as significantly lower CPa in females when compared to males at rest. Similarly, CSa was significantly lower in females when compared to males. Both pulmonary and systemic effective arterial elastance were also higher at rest in females compared to males. These findings may help to contextualize the hemodynamics of systemic and pulmonary ventricular-vascular units measured in disease states, by contributing uncommonly available physiologic data from healthy humans. In addition to the sex-based comparisons, even amongst the narrow age range of subjects recruited in this study, we were able to demonstrate relationships between both systemic and pulmonary vascular pulsatile loading and age. The recruitment criteria for this study resulted in a cohort of individuals with similar BMI without significant comorbidities which minimized the requirement to adjust for confounding variables.
In the systemic circuit, we identified lower Csa and increased SEa in females. These findings are consistent with increased arterial stiffness and higher arterial pulsatile loading in females, supportive of data reported by other investigators using non-invasive methodology.11 It has been hypothesized that the female predilection of HFpEF is based on the interaction between sex and aging on ventricular-vascular coupling and higher systemic pulsatile loading. Our data confirms that even in a healthy cohort of individuals within a narrow age range, females have markers of higher arterial load and that there is also a detectable effect of age. The predisposition to HFpEF is likely multi-factorial and related to chronic exposure to several pathologic features that are also affected by sex.19 Our findings are consistent with the notion that both age and female sex increase vulnerability when exposed to risk factors that accelerate vascular stiffening such as hypertension or obesity.9
We examined several measures of pulmonary vascular function, including the calculation of pulmonary effective arterial elastance, which has been referred to as a “lumped” parameter of RV afterload.16 It is a summative measure representative of the resistive load across the pulmonary vasculature, the pulsatile load in systole and related downstream influence of the PAWP. Our data showed pulmonary effective arterial elastance was significantly greater in females. This appeared to be related to higher pulsatile afterload as Cpa was lower in females, while in contrast, resistive load across the pulmonary vasculature was not different between females and males.20 Lam et al have provided evidence that links higher pulmonary artery pressure in older adults to evidence of systemic arterial stiffening.21 Our observations of systemic and pulmonary vascular characteristics are supportive of this notion particularly in females, but the cross sectional nature precludes assumptions of causality.
During exercise, as expected, SVR declined as did Csa without significant differences between males and females. As we have previously reported, Cpa declined steadily with increasing exercise effort15 with only a trend to lower Cpa at each exercise stage in females. The analysis further demonstrates that sex does not alter the relationship between PVR and Cpa during dynamic exercise, as the behaviour of the RC-time product was similar between males and females. Although we observed sex differences in resting measures of vascular resistance and compliance, with the stimulus of exercise, sex differences were not as discernible. However, effective pulmonary elastance remained higher in females suggesting higher RV afterload persists in females with exercise.
Although we recruited individuals within a narrow range of age (45-74y), secondary analyses still demonstrated significant relationships between age and both pulmonary and systemic compliance and elastance indices. This confirms, using invasive hemodynamic measurements, the findings of other investigators that large artery stiffness increases, or becomes less compliant with age in both the pulmonary and the systemic circulation.4,21 In this study, our lower age range was confined to age > 45 years as changes in arterial properties are likely not linear over the lifespan. In both sexes, there may be effects of changing sex steroid hormone status, and possibly the subclinical onset of vascular risk factors. Our findings are relevant to the hypothesized role of increased arterial stiffness in pathologic conditions, such as HFpEF and are consistent with the observed predilection of females to both increased stiffness and HFpEF.5,10 A recent study by Lau et al. demonstrated that amongst individuals with HFpEF, females have significantly higher measures of arterial stiffness than males, in addition to abnormal steep increases in PAWP during exercise. They assessed arterial stiffness via augmentation pressure and index as well as aortic pulse pressure. They also demonstrated that these measures of arterial stiffness were associated with a greater PAWP/CO slope, with a higher odds ratio in females, suggesting higher indices of arterial stiffness with exercise. The current study provides further evidence for increased stiffness in healthy females compared to males as estimated by systemic and pulmonary compliance derived from right heart catheterization. This is in line with the concept that even healthy middle-aged females sustain chronic exposures of both the RV and LV to stiffer vasculatures which, in turn may contribute towards the development of HFpEF with aging.19
In this study, we should acknowledge that the calculation of compliance or elastance and resistance are highly dependent on measurement of SV and CO, respectively, which in turn are systematically different between males and females. Other methods to assess vascular compliance employ assessment of the geometric changes in systole and diastole,22 but are also affected by baseline differences in vessel size. Measures of vascular resistance were expressed indexed to body surface area, as well as height.13 Even so, such adjustments remain affected by systematic sex differences in body habitus, not necessarily reflected in weight or height. As noted, our findings, at least with respect to Csa and SVR, are in agreement with other investigators employing different techniques of measurement.5,16 For investigations using similar RHC methods, the current data highlight the need to contextualize measurements with sex specific comparator controls and if possible, obtain supporting evidence using other methods.
Limitations
There are several limitations to our analysis. Based on the invasive methods, we assessed a relatively small sample of healthy individuals and may have been underpowered to compare the vascular measurements. The original investigation was powered to evaluate exercise changes in PAWP between males and females, and in fact we did observe baseline differences in PCWP. There are inherent drawbacks to the use of fluid-filled catheters, with respect to wave reflection and the time response. The limitations of the calculations employed for compliance and resistance were noted. The estimation of Cpa assumes that the proximal pulmonary arteries are exposed to the entire SV in a closed system and does not take into account the volume leaving the pulmonary circulation during exercise.20,23,24 Pulmonary effective arterial elastance was calculated using the ratio of mPAP to SV, which assumes the RV pressure at end-diastolic volume equals zero.25 In addition, there was a difference in age between our two groups, although this was accounted for by adjusting all variables for age.